Drug Adherence Impacts Multiple Sclerosis Outcomes
In the past two decades, several disease-modifying therapies
(DMTs) have become available for the treatment of relapsing-onset
multiple sclerosis (MS). While all DMTs reduce disease activity
to some extent, the efficacy rates vary.However, the success of
any pharmacological management for MS relies on the adherence
and persistence to the prescribed therapy; even the most potent DMT
will have little benefit if the drug is not taken, or not taken correctly.
Modern Medicine – August 2017
